Clincosm LogoSign in Get a demo

Lymphoma, Non-Hodgkin

Showing NaN - NaN of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin Trial in Worldwide (Fludarabine, Cyclophosphamide, JCAR017)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Santa Monica, California
  • +36 more
Jan 25, 2023

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (JCAR017, Durvalumab,

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • JCAR017
  • +7 more
  • Duarte, California
  • +17 more
Jan 13, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (Standard of Care, JCAR017)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Standard of Care
  • JCAR017
  • Phoenix, Arizona
  • +78 more
Jan 13, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (Ibrutinib, Rituximab, Ifosfamide)

Terminated
Has Results
  • Lymphoma, Non-Hodgkin
  • Los Angeles, California
  • +76 more
Nov 7, 2022

Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in Worldwide (pembrolizumab, Favezelimab)

Recruiting
  • Hodgkin Disease
  • +2 more
  • pembrolizumab
  • Favezelimab
  • Gilbert, Arizona
  • +24 more
Aug 18, 2022

Lymphoma, Non-Hodgkin Trial in Worldwide (CC-99282, Obinutuzumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Boston, Massachusetts
  • +17 more
Aug 1, 2022

Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Lymphoma, B-Cell
  • +4 more
  • Burbank, California
  • +90 more
Mar 31, 2022

Lymphoma, Non-Hodgkin Trial in Canada, United States (TAK-659, Bendamustine, Rituximab)

Terminated
Has Results
  • Lymphoma, Non-Hodgkin
  • Tucson, Arizona
  • +12 more
Dec 7, 2021

Lymphoma, Non-Hodgkin Trial in United States (Hematopoietic Stem Cell Transplant)

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • Hematopoietic Stem Cell Transplant
  • Duarte, California
  • +20 more
Dec 7, 2021

Lymphoma, Non-Hodgkin, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)

Completed
  • Lymphoma, Non-Hodgkin
  • HIV Infections
  • Bleomycin sulfate
  • +9 more
  • Los Angeles, California
  • +21 more
Oct 26, 2021

Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Non-Hodgkin Trial in United States (Autologous transplantation

Completed
Has Results
  • Lymphoma, B-Cell
  • +2 more
  • Autologous transplantation using rituxan/BEAM
  • Autologous transplantation using Bexxar/BEAM
  • New Haven, Connecticut
  • +35 more
Oct 21, 2021

Hematologic Malignancy, Leukemia, Lymphoma Trial in Boston (CAR-37 T cells)

Recruiting
  • Hematologic Malignancy
  • +5 more
  • CAR-37 T cells
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Oct 28, 2021

Lymphoma, Non-Hodgkin, Lymphoma, Large B-cell, Diffuse, Lymphoma, Follicular Trial in Canada, Germany, United States (TAK-659,

Completed
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +14 more
Aug 23, 2021

Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)

No longer available
  • Disease, Hodgkin
  • +3 more
  • brentuximab vedotin
  • Stanford, California
  • +30 more
Sep 17, 2020

Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (PF-05082566, rituximab)

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • +6 more
  • Duarte, California
  • +41 more
Mar 4, 2020

Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin Trial in United States (Idelalisib)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • Lymphoma, Non-Hodgkin
  • Huntsville, Alabama
  • +17 more
Aug 22, 2019

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Diffuse Trial in Boston (GM-CSF, CHOP, Rituximab)

Terminated
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jan 16, 2018

Lymphoma, Non-Hodgkin, Chronic Lymphocytic Leukemia Trial in Switzerland, United States (IMGN529)

Completed
  • Lymphoma, Non-Hodgkin
  • Chronic Lymphocytic Leukemia
  • Boston, Massachusetts
  • +6 more
Dec 27, 2017

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in Canada, United States (brentuximab vedotin,

Completed
Has Results
  • Lymphoma, B-Cell
  • +3 more
  • Birmingham, Alabama
  • +33 more
Oct 14, 2016

Lymphoma, Non-Hodgkin, MALT Lymphoma Trial in Boston, Rochester (Fludarabine, Rituximab)

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • MALT Lymphoma
  • Boston, Massachusetts
  • +3 more
Jul 28, 2016

Lymphoma, Non-Hodgkin Trial in Canada, United States (Granulocyte colony-stimulating factor plus plerixafor, Granulocyte

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • Granulocyte colony-stimulating factor plus plerixafor
  • Granulocyte colony-stimulating factor plus placebo
  • Phoenix, Arizona
  • +31 more
Feb 10, 2014

Lymphoma, Non-Hodgkin, HIV Trial in United States (Filgrastim, Vincristine sulfate, Doxorubicin HCl)

Completed
  • Lymphoma, Non-Hodgkin
  • HIV Infections
  • San Francisco, California
  • +6 more
Oct 31, 2012

A Study of Patients With AIDS Syndrome

Completed
  • Sarcoma, Kaposi
  • +3 more
    • Menlo Park, California
    • +22 more
    Sep 11, 2008

    Tumors, Lymphoma, Non-Hodgkin Trial in Boston, Philadelphia (AG-024322)

    Terminated
    • Neoplasms
    • Lymphoma, Non-Hodgkin
    • Boston, Massachusetts
    • +3 more
    Aug 14, 2008